Cargando…
PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429679/ http://dx.doi.org/10.1097/01.HS9.0000975896.32740.f9 |
_version_ | 1785090773305262080 |
---|---|
author | Garcia, Alberto Lopez Macia, Ester Gomez-Talavera, Sandra Castillo-Bazan, Eva Morillo, Daniel Ibañez, Borja Cordoba, Raul |
author_facet | Garcia, Alberto Lopez Macia, Ester Gomez-Talavera, Sandra Castillo-Bazan, Eva Morillo, Daniel Ibañez, Borja Cordoba, Raul |
author_sort | Garcia, Alberto Lopez |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104296792023-08-17 PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES Garcia, Alberto Lopez Macia, Ester Gomez-Talavera, Sandra Castillo-Bazan, Eva Morillo, Daniel Ibañez, Borja Cordoba, Raul Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429679/ http://dx.doi.org/10.1097/01.HS9.0000975896.32740.f9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Garcia, Alberto Lopez Macia, Ester Gomez-Talavera, Sandra Castillo-Bazan, Eva Morillo, Daniel Ibañez, Borja Cordoba, Raul PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES |
title | PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES |
title_full | PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES |
title_fullStr | PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES |
title_full_unstemmed | PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES |
title_short | PB2292: DEVELOPMENT OF CARDIOTOXICITY NEGATIVELY IMPACTS IN OVERALL SURVIVAL IN PATIENTS WITH LYMPHOMA TREATED WITH FIRST-LINE ANTHRACYCLINES |
title_sort | pb2292: development of cardiotoxicity negatively impacts in overall survival in patients with lymphoma treated with first-line anthracyclines |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429679/ http://dx.doi.org/10.1097/01.HS9.0000975896.32740.f9 |
work_keys_str_mv | AT garciaalbertolopez pb2292developmentofcardiotoxicitynegativelyimpactsinoverallsurvivalinpatientswithlymphomatreatedwithfirstlineanthracyclines AT maciaester pb2292developmentofcardiotoxicitynegativelyimpactsinoverallsurvivalinpatientswithlymphomatreatedwithfirstlineanthracyclines AT gomeztalaverasandra pb2292developmentofcardiotoxicitynegativelyimpactsinoverallsurvivalinpatientswithlymphomatreatedwithfirstlineanthracyclines AT castillobazaneva pb2292developmentofcardiotoxicitynegativelyimpactsinoverallsurvivalinpatientswithlymphomatreatedwithfirstlineanthracyclines AT morillodaniel pb2292developmentofcardiotoxicitynegativelyimpactsinoverallsurvivalinpatientswithlymphomatreatedwithfirstlineanthracyclines AT ibanezborja pb2292developmentofcardiotoxicitynegativelyimpactsinoverallsurvivalinpatientswithlymphomatreatedwithfirstlineanthracyclines AT cordobaraul pb2292developmentofcardiotoxicitynegativelyimpactsinoverallsurvivalinpatientswithlymphomatreatedwithfirstlineanthracyclines |